SMMT
Price
$19.13
Change
-$0.31 (-1.59%)
Updated
Sep 9, 11:07 AM (EDT)
Capitalization
14.44B
57 days until earnings call
SPRY
Price
$10.70
Change
+$0.63 (+6.26%)
Updated
Sep 8 closing price
Capitalization
1.06B
58 days until earnings call
Interact to see
Advertisement

SMMT vs SPRY

Header iconSMMT vs SPRY Comparison
Open Charts SMMT vs SPRYBanner chart's image
Summit Therapeutics
Price$19.13
Change-$0.31 (-1.59%)
Volume$96.35K
Capitalization14.44B
ARS Pharmaceuticals
Price$10.70
Change+$0.63 (+6.26%)
Volume$5.08M
Capitalization1.06B
SMMT vs SPRY Comparison Chart in %
Loading...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SMMT vs. SPRY commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMMT is a StrongBuy and SPRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (SMMT: $19.44 vs. SPRY: $10.70)
Brand notoriety: SMMT and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SMMT: 493% vs. SPRY: 243%
Market capitalization -- SMMT: $14.44B vs. SPRY: $1.06B
SMMT [@Biotechnology] is valued at $14.44B. SPRY’s [@Biotechnology] market capitalization is $1.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SMMT’s FA Score shows that 1 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • SMMT’s FA Score: 1 green, 4 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, SMMT is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SMMT’s TA Score shows that 4 TA indicator(s) are bullish while SPRY’s TA Score has 4 bullish TA indicator(s).

  • SMMT’s TA Score: 4 bullish, 6 bearish.
  • SPRY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SPRY is a better buy in the short-term than SMMT.

Price Growth

SMMT (@Biotechnology) experienced а -17.95% price change this week, while SPRY (@Biotechnology) price change was -7.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.33%. For the same industry, the average monthly price growth was +10.85%, and the average quarterly price growth was +35.23%.

Reported Earning Dates

SMMT is expected to report earnings on Nov 05, 2025.

SPRY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($14.4B) has a higher market cap than SPRY($1.06B). SPRY has higher P/E ratio than SMMT: SPRY (151.25) vs SMMT (26.36). SMMT YTD gains are higher at: 8.966 vs. SPRY (1.422). SPRY has higher annual earnings (EBITDA): -59.34M vs. SMMT (-743.48M). SMMT has more cash in the bank: 298M vs. SPRY (240M). SPRY has less debt than SMMT: SPRY (1.66M) vs SMMT (5.55M). SPRY has higher revenues than SMMT: SPRY (112M) vs SMMT (0).
SMMTSPRYSMMT / SPRY
Capitalization14.4B1.06B1,362%
EBITDA-743.48M-59.34M1,253%
Gain YTD8.9661.422631%
P/E Ratio26.36151.2517%
Revenue0112M-
Total Cash298M240M124%
Total Debt5.55M1.66M334%
FUNDAMENTALS RATINGS
SMMT: Fundamental Ratings
SMMT
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
51
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SMMTSPRY
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 15 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NEMAX24.32N/A
N/A
Neuberger Berman Emerg Mkts Eq A
MTRBX20.16N/A
N/A
MFS Total Return B
NWJEX115.34N/A
N/A
Nationwide NYSE Arca Tech 100 Idx R6
JGISX94.83N/A
N/A
JPMorgan U.S. GARP Equity R6
FSEBX14.23N/A
N/A
Fidelity Sustainable U.S. Equity Fund